Skip to content

RACE Concussion Study: Rapid, accurate assessment of blood biomarkers for concussion

We are investigating if biosensor can accurately measure blood biomarkers of concussion. Concussion diagnoses and prognoses are currently reliant on subjective measures. A biosensor that can objectively measure concussion could supplement subjective measures. This would allow early diagnosis or recovery monitoring to reduce recovery times.

All participants in this study will complete initial visit measures upon enrolment. These include questionnaires (15 minutes) and a blood draw (5 minutes). Participants with concussion will return for follow-up visits at 2, 6, and 12 weeks after injury or until recovery. They will also complete a daily online symptom survey (2 minutes), and be given access to concussion education resources. Participants with a muscular or skeletal injury will only complete initial visit measures.

null

Conditions de participation

  • Sexe:

    Male, Female, Intersex

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:
1) Concussion OR muskuloskeletal injury (broken bone, pulled muscle, connective tissue damage, etc.) diagnosis within one week before first study visit.
2) Ages 18 through 100 years old

Exclusion Criteria:
1) History of neurological diseases (stroke, seizures, epilepsy, dementia, etc.)
2) Current metabolic disease (liver disease, kidney disease, cardiovascular disease, diabetes, etc.)
3) A prior moderate or severe brain injury
4) Any secondary injury during the same time as the concussion or musculoskeletal injury

Lieu de l'étude

University of Calgary
University of Calgary
Calgary, Alberta
Canada

Contactez l'équipe d'étude

Étude parrainée par
University of Calgary
Participants recherchés
Plus d'informations
ID de l'étude: REB22-1015